These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 30352075)

  • 1. Generation of a TP53-modified porcine cancer model by CRISPR/Cas9-mediated gene modification in porcine zygotes via electroporation.
    Tanihara F; Hirata M; Nguyen NT; Le QA; Hirano T; Takemoto T; Nakai M; Fuchimoto DI; Otoi T
    PLoS One; 2018; 13(10):e0206360. PubMed ID: 30352075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of PDX-1 mutant porcine blastocysts by introducing CRISPR/Cas9-system into porcine zygotes via electroporation.
    Tanihara F; Hirata M; Nguyen NT; Le QA; Hirano T; Takemoto T; Nakai M; Fuchimoto DI; Otoi T
    Anim Sci J; 2019 Jan; 90(1):55-61. PubMed ID: 30368976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient generation of GGTA1-deficient pigs by electroporation of the CRISPR/Cas9 system into in vitro-fertilized zygotes.
    Tanihara F; Hirata M; Nguyen NT; Sawamoto O; Kikuchi T; Doi M; Otoi T
    BMC Biotechnol; 2020 Aug; 20(1):40. PubMed ID: 32811500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of
    Tanihara F; Hirata M; Nguyen NT; Le QA; Wittayarat M; Fahrudin M; Hirano T; Otoi T
    Anim Biotechnol; 2021 Apr; 32(2):147-154. PubMed ID: 31558095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient production of biallelic GGTA1 knockout pigs by cytoplasmic microinjection of CRISPR/Cas9 into zygotes.
    Petersen B; Frenzel A; Lucas-Hahn A; Herrmann D; Hassel P; Klein S; Ziegler M; Hadeler KG; Niemann H
    Xenotransplantation; 2016 Sep; 23(5):338-46. PubMed ID: 27610605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of mosaic mutation by co-delivery of CRISPR associated protein 9 and three-prime repair exonuclease 2 into porcine zygotes via electroporation.
    Yamashita S; Kogasaka Y; Hiradate Y; Tanemura K; Sendai Y
    J Reprod Dev; 2020 Feb; 66(1):41-48. PubMed ID: 31761839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of viable PDX1 gene-edited founder pigs as providers of nonmosaics.
    Tanihara F; Hirata M; Thi Nguyen N; Anh Le Q; Hirano T; Otoi T
    Mol Reprod Dev; 2020 Apr; 87(4):471-481. PubMed ID: 32166879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmed cell death-1-modified pig developed using electroporation-mediated gene editing for in vitro fertilized zygotes.
    Nguyen TV; Do LTK; Lin Q; Nagahara M; Namula Z; Wittayarat M; Hirata M; Otoi T; Tanihara F
    In Vitro Cell Dev Biol Anim; 2024 Aug; 60(7):716-724. PubMed ID: 38485817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental competence of porcine genome-edited zygotes.
    Gil MA; Martinez CA; Nohalez A; Parrilla I; Roca J; Wu J; Ross PJ; Cuello C; Izpisua JC; Martinez EA
    Mol Reprod Dev; 2017 Sep; 84(9):814-821. PubMed ID: 28471514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GEEP Method: An Optimized Electroporation-Mediated Gene Editing Approach for Establishment of Knockout Pig Lines.
    Tanihara F; Hirata M; Otoi T
    Methods Mol Biol; 2023; 2637():293-300. PubMed ID: 36773155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porcine Zygote Injection with Cas9/sgRNA Results in DMD-Modified Pig with Muscle Dystrophy.
    Yu HH; Zhao H; Qing YB; Pan WR; Jia BY; Zhao HY; Huang XX; Wei HJ
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27735844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome mutation after introduction of the gene editing by electroporation of Cas9 protein (GEEP) system in matured oocytes and putative zygotes.
    Hirata M; Tanihara F; Wittayarat M; Hirano T; Nguyen NT; Le QA; Namula Z; Nii M; Otoi T
    In Vitro Cell Dev Biol Anim; 2019 Apr; 55(4):237-242. PubMed ID: 30820813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroporation Delivery of Cas9 sgRNA Ribonucleoprotein-Mediated Genome Editing in Sheep IVF Zygotes.
    Pi W; Feng G; Liu M; Nie C; Chen C; Wang J; Wang L; Wan P; Liu C; Liu Y; Zhou P
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-Step Generation of Multiple Gene-Edited Pigs by Electroporation of the CRISPR/Cas9 System into Zygotes to Reduce Xenoantigen Biosynthesis.
    Tanihara F; Hirata M; Nguyen NT; Sawamoto O; Kikuchi T; Otoi T
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of CRISPR-Cas9 into Mouse Zygotes by Electroporation.
    Qin W; Wang H
    Methods Mol Biol; 2019; 1874():179-190. PubMed ID: 30353514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of GHR-modified pigs as Laron syndrome models via a dual-sgRNAs/Cas9 system and somatic cell nuclear transfer.
    Yu H; Long W; Zhang X; Xu K; Guo J; Zhao H; Li H; Qing Y; Pan W; Jia B; Zhao HY; Huang X; Wei HJ
    J Transl Med; 2018 Feb; 16(1):41. PubMed ID: 29482569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroporation of Cas9 protein/sgRNA into early pronuclear zygotes generates non-mosaic mutants in the mouse.
    Hashimoto M; Yamashita Y; Takemoto T
    Dev Biol; 2016 Oct; 418(1):1-9. PubMed ID: 27474397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient generation of P53 biallelic knockout Diannan miniature pigs via TALENs and somatic cell nuclear transfer.
    Shen Y; Xu K; Yuan Z; Guo J; Zhao H; Zhang X; Zhao L; Qing Y; Li H; Pan W; Jia B; Zhao HY; Wei HJ
    J Transl Med; 2017 Nov; 15(1):224. PubMed ID: 29100547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of introducing the CRISPR/Cas9 system by microinjection and electroporation into porcine embryos at different stages.
    Le QA; Tanihara F; Wittayarat M; Namula Z; Sato Y; Lin Q; Takebayashi K; Hirata M; Otoi T
    BMC Res Notes; 2021 Jan; 14(1):7. PubMed ID: 33407863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoring the p53 'Guardian' Phenotype in p53-Deficient Tumor Cells with CRISPR/Cas9.
    Chira S; Gulei D; Hajitou A; Berindan-Neagoe I
    Trends Biotechnol; 2018 Jul; 36(7):653-660. PubMed ID: 29478674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.